BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37868624)

  • 1. Evidence for some, extrapolation for others: Levonorgestrel IUDs and health equity in Gynecologic Oncology.
    Matthews BJ; Fiascone SJ
    Gynecol Oncol Rep; 2023 Oct; 49():101285. PubMed ID: 37868624
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained intrauterine release of levonorgestrel over five years.
    Nilsson CG; Lahteenmaki PL; Luukkainen T; Robertson DN
    Fertil Steril; 1986 Jun; 45(6):805-7. PubMed ID: 3086130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lost levonorgestrel IUD: diagnosis and therapy.
    Nitke S; Rabinerson D; Dekel A; Sheiner E; Kaplan B; Hackmon R
    Contraception; 2004 Apr; 69(4):289-93. PubMed ID: 15033403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential association between psychiatric symptoms and the use of levonorgestrel intrauterine devices (LNG-IUDs): A systematic review.
    Elsayed M; Dardeer KT; Khehra N; Padda I; Graf H; Soliman A; Makram AM; Zeiss R; Schönfeldt-Lecuona C
    World J Biol Psychiatry; 2023; 24(6):457-475. PubMed ID: 36426589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five years' experience with levonorgestrel-releasing IUDs.
    Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
    Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial morphological changes in IUD users: a review.
    Sheppard BL
    Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care provider attitudes and practices related to intrauterine devices for nulliparous women.
    Tyler CP; Whiteman MK; Zapata LB; Curtis KM; Hillis SD; Marchbanks PA
    Obstet Gynecol; 2012 Apr; 119(4):762-71. PubMed ID: 22433340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.
    Turok DK; Gero A; Simmons RG; Kaiser JE; Stoddard GJ; Sexsmith CD; Gawron LM; Sanders JN
    N Engl J Med; 2021 Jan; 384(4):335-344. PubMed ID: 33503342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of IUDs is increasing.
    Finger WR; Barr D
    Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TCu-380A (AG), MLCu375, and Nova-T IUDs and the IUD daily releasing 20 micrograms levonorgestrel--four pillars of IUD contraception for the nineties and beyond?
    Chi IC
    Contraception; 1993 Apr; 47(4):325-47. PubMed ID: 8508663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Background parenchymal enhancement in contrast-enhanced MR imaging suggests systemic effects of intrauterine contraceptive devices.
    Huck LC; Truhn D; Wilpert C; Zanderigo E; Raaff V; Dethlefsen E; Bode M; Kuhl CK
    Eur Radiol; 2022 Nov; 32(11):7430-7438. PubMed ID: 35524784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine devices: an update.
    Hardeman J; Weiss BD
    Am Fam Physician; 2014 Mar; 89(6):445-50. PubMed ID: 24695563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intra-uterine devices.
    Nilsson CG; Lähteenmäki P; Robertson DN; Luukkainen T
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):380-4. PubMed ID: 7376797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine Device Use in Adolescents With Disabilities.
    Schwartz BI; Alexander M; Breech LL
    Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32719107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.